Study: Risk of cardiovascular events doubles with use of low-dose oral contraceptives

07/13/2005 | Medscape (free registration)

A new study links use of low-dose oral contraceptives with a higher risk of cardiac as well as vascular arterial events. While previous studies on the association have produced inconsistent results, the new research -- the meta-analysis of 14 studies -- shows that overall, use of low-dose oral contraceptives was associated with a doubling of the risk of cardiovascular outcomes.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA